D.A. Davidson & CO. boosted its position in CME Group Inc. (NASDAQ:CME – Free Report) by 1.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,845 shares of the financial services provider’s stock after purchasing an additional 390 shares during the quarter. D.A. Davidson & CO.’s holdings in CME Group were worth $5,331,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also bought and sold shares of the company. Balentine LLC lifted its stake in CME Group by 44.9% in the 4th quarter. Balentine LLC now owns 8,870 shares of the financial services provider’s stock worth $1,492,000 after purchasing an additional 2,748 shares in the last quarter. Aigen Investment Management LP purchased a new stake in shares of CME Group during the 4th quarter valued at $1,453,000. Clear Street Markets LLC raised its position in shares of CME Group by 25.1% during the 4th quarter. Clear Street Markets LLC now owns 564 shares of the financial services provider’s stock valued at $95,000 after buying an additional 113 shares in the last quarter. Gradient Investments LLC raised its position in shares of CME Group by 5.5% during the 1st quarter. Gradient Investments LLC now owns 87,930 shares of the financial services provider’s stock valued at $16,840,000 after buying an additional 4,569 shares in the last quarter. Finally, Xponance Inc. raised its position in shares of CME Group by 14.6% during the 4th quarter. Xponance Inc. now owns 42,386 shares of the financial services provider’s stock valued at $7,128,000 after buying an additional 5,394 shares in the last quarter. 85.98% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several analysts have recently weighed in on CME shares. Morgan Stanley raised their price objective on shares of CME Group from $201.00 to $208.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 11th. Rosenblatt Securities raised their price objective on shares of CME Group from $161.00 to $169.00 in a research report on Thursday. StockNews.com started coverage on shares of CME Group in a research report on Thursday, May 18th. They set a “hold” rating on the stock. Barclays began coverage on shares of CME Group in a research report on Wednesday, June 28th. They set an “overweight” rating and a $215.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of CME Group from $206.00 to $208.00 in a report on Thursday, April 27th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, CME Group presently has an average rating of “Moderate Buy” and an average price target of $209.30.
CME Group Price Performance
CME Group (NASDAQ:CME – Free Report) last announced its quarterly earnings results on Wednesday, April 26th. The financial services provider reported $2.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.36 by $0.06. The business had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.42 billion. CME Group had a net margin of 55.99% and a return on equity of 10.88%. The company’s revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the firm earned $2.11 EPS. As a group, equities analysts expect that CME Group Inc. will post 8.74 EPS for the current year.
CME Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, June 27th. Shareholders of record on Friday, June 9th were issued a $1.10 dividend. This represents a $4.40 dividend on an annualized basis and a yield of 2.42%. The ex-dividend date of this dividend was Thursday, June 8th. CME Group’s dividend payout ratio (DPR) is presently 55.91%.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- Gorilla Technology Skyrockets 124% On Smart Government Contract
- Why Buying The Dip In Alphabet (Google) Could Yield Big Returns
- EV Mixed Signals: Sales Are Rising, But Inventory Slower To Move
- MarketBeat Week in Review – 7/3 – 7/7
- Pfizer Just Invested $25 million In This Biotech
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
